Hot Features
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) acro... Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.8 | -29.7397769517 | 2.69 | 2.88 | 1.77 | 60759 | 2.2217571 | CS |
| 4 | -1.26 | -40 | 3.15 | 3.2 | 1.71 | 48779 | 2.47530442 | CS |
| 12 | -2.21 | -53.9024390244 | 4.1 | 4.15 | 1.71 | 25939 | 2.8062869 | CS |
| 26 | -3.52 | -65.0646950092 | 5.41 | 6.645 | 1.71 | 28329 | 3.96875558 | CS |
| 52 | -3.62 | -65.6987295826 | 5.51 | 9.5 | 1.71 | 193678 | 6.54902246 | CS |
| 156 | 0.51 | 36.9565217391 | 1.38 | 36 | 0.2914 | 504561 | 3.53371779 | CS |
| 260 | 0.36 | 23.5294117647 | 1.53 | 36 | 0.0846 | 1808804 | 0.87875585 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.